| Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients A Serretti, M Kato, D De Ronchi, T Kinoshita Molecular psychiatry 12 (3), 247-257, 2007 | 619 | 2007 |
| Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder M Kato, A Serretti Molecular psychiatry 15 (5), 473-500, 2010 | 535 | 2010 |
| Convergent transcriptional specializations in the brains of humans and song-learning birds AR Pfenning, E Hara, O Whitney, MV Rivas, R Wang, PL Roulhac, ... Science 346 (6215), 1256846, 2014 | 511 | 2014 |
| ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder M Kato, T Fukuda, A Serretti, M Wakeno, G Okugawa, Y Ikenaga, Y Hosoi, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2), 398-404, 2008 | 186 | 2008 |
| Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese … M Kato, T Fukuda, M Wakeno, K Fukuda, G Okugawa, Y Ikenaga, ... Neuropsychobiology 53 (4), 186-195, 2006 | 179 | 2006 |
| The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response JM Biernacka, K Sangkuhl, G Jenkins, RM Whaley, P Barman, A Batzler, ... Translational psychiatry 5 (4), e553-e553, 2015 | 144 | 2015 |
| A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin M Nagae, K Morita-Matsumoto, M Kato, MK Kaneko, Y Kato, Y Yamaguchi Structure 22 (12), 1711-1721, 2014 | 122 | 2014 |
| Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis M Kato, H Hori, T Inoue, J Iga, M Iwata, T Inagaki, K Shinohara, H Imai, ... Molecular psychiatry 26 (1), 118-133, 2021 | 119 | 2021 |
| Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder M Kato, T Fukuda, M Wakeno, G Okugawa, Y Takekita, S Watanabe, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009 | 108 | 2009 |
| Second-generation antipsychotics in the treatment of major depressive disorder: current evidence C Han, SM Wang, M Kato, SJ Lee, AA Patkar, PS Masand, CU Pae Expert review of neurotherapeutics 13 (7), 851-870, 2013 | 95 | 2013 |
| Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism M Kato, Y Ikenaga, M Wakeno, G Okugawa, K Nobuhara, T Fukuda, ... International clinical psychopharmacology 20 (3), 151-156, 2005 | 95 | 2005 |
| Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA K Nishida, M Yoshimura, T Isotani, T Yoshida, Y Kitaura, A Saito, H Mii, ... Clinical Neurophysiology 122 (9), 1718-1725, 2011 | 94 | 2011 |
| A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing M Kato, K Takemoto, Y Shinkai Nature communications 9 (1), 1683, 2018 | 92 | 2018 |
| Pharmacogenetic studies in depression: a proposal for methodologic guidelines A Serretti, M Kato, JL Kennedy The pharmacogenomics journal 8 (2), 90-100, 2008 | 92 | 2008 |
| The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression Y Kageyama, T Kasahara, M Kato, S Sakai, Y Deguchi, M Tani, K Kuroda, ... Journal of affective disorders 233, 15-20, 2018 | 91 | 2018 |
| Estimated cognitive decline in patients with schizophrenia: A multicenter study H Fujino, C Sumiyoshi, Y Yasuda, H Yamamori, M Fujimoto, M Fukunaga, ... Psychiatry and clinical neurosciences 71 (5), 294-300, 2017 | 74 | 2017 |
| Association of HLA-A* 31: 01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population T Mushiroda, Y Takahashi, T Onuma, Y Yamamoto, T Kamei, T Hoshida, ... JAMA neurology 75 (7), 842-849, 2018 | 68 | 2018 |
| Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression M Kato, CM Chang CNS drugs 27 (Suppl 1), 11-19, 2013 | 62 | 2013 |
| Identifying the common genetic basis of antidepressant response O Pain, K Hodgson, V Trubetskoy, S Ripke, VS Marshe, MJ Adams, ... Biological psychiatry global open science 2 (2), 115-126, 2022 | 55 | 2022 |
| Association of the polygenic scores for personality traits and response to selective serotonin reuptake inhibitors in patients with major depressive disorder AT Amare, KO Schubert, F Tekola-Ayele, YH Hsu, K Sangkuhl, G Jenkins, ... Frontiers in psychiatry 9, 65, 2018 | 50 | 2018 |
Yoshiteru TakekitaKansai Medical University在 takii.kmu.ac.jp 的电子邮件经过验证
